U.S., Aug. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07144020) titled 'Donor Derived CD117 CAR-T Cells in the Treatment of R/R Acute Myeloid Leukemia' on Aug. 20.
Brief Summary: A Clinical Study on the Safety and Effectiveness of Donor Derived CD117 CAR-T Cell in the treatment of Relapsed/Refractory Acute Myeloid Leukemia
Study Start Date: Sept. 05
Study Type: INTERVENTIONAL
Condition:
Acute Myeloid Leukemia
Intervention:
BIOLOGICAL: CD117 CAR T-cells
Each subject receive CD117 CAR T-cells by intravenous infusion
Recruitment Status: RECRUITING
Sponsor: Zhejiang University
Information provided by (Responsible Party): He Huang, First Affiliated Hospital of Zhejiang University
Disclaimer: Curat...